DC
Decheng Capital Portfolio holdings
AUM
$396M
This Quarter Return
-23.9%
1 Year Return
-5.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$356M
AUM Growth
+$356M
(-24%)
Cap. Flow
+$9.61M
Cap. Flow
% of AUM
2.7%
Top 10 Holdings %
Top 10 Hldgs %
86.5%
Holding
29
New
1
Increased
2
Reduced
8
Closed
2
Top Buys
| 1 |
AARD
Aardvark Therapeutics, Inc. Common Stock
AARD
|
$29.4M |
| 2 |
Aclaris Therapeutics
ACRS
|
$2.72M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$335K |
Top Sells
| 1 |
Illumina
ILMN
|
$6.59M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$5.64M |
| 3 |
Arcellx
ACLX
|
$2.26M |
| 4 |
Krystal Biotech
KRYS
|
$2.12M |
| 5 |
BioNTech
BNTX
|
$1.82M |
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vera Therapeutics
VERA
$1.47B
| $108K | 0.03% |
4,495
-45,272
| -91% | -$1.09M |
|
27
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
| $44K | 0.01% |
646,057
| – | – |
|
|
28
Phathom Pharmaceuticals
PHAT
$843M
| – | – |
-694,254
| Closed | -$5.64M |
|
29
AtriCure
ATRC
$1.73B
| – | – |
-26,797
| Closed | -$819K |
|